Magenta Medical Ltd.

[ Editor's Note: Due to a technical issue, some of this article did not appear online when it was originally published on 1 November, so we are republishing it in its entirety. ] Johnson & Johnson

Israeli acute heart failure (HF) therapy firm Magenta Medical Ltd. has bulked up its coffers with an additional $15m, following a Series B financing that brought in new investors from Japan and th

IN VITRO DIAGNOSTICS Drug Response Dx GMBH Drug Response Dx closes Series A round Start-up diagnostics firm Drug Response Dx GMBH has raised an undisclosed amount in its Series A financing to

Elsevier’s Strategic Transactions